C12N 2310/3519
Fusion with another nucleic acid
C12N2310/3519 (Fusion with another nucleic acid) appears on 605 US grants and 1,274 published applications in this corpus.
Search patents in C12N- Granted patents
- 605
- Published applications
- 1,274
- Assignees
- 457
- Inventors
- 1,811
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 2 |
| 2003 | 1 | 9 |
| 2004 | 0 | 11 |
| 2005 | 0 | 8 |
| 2006 | 1 | 17 |
| 2007 | 1 | 9 |
| 2008 | 2 | 19 |
| 2009 | 3 | 19 |
| 2010 | 4 | 20 |
| 2011 | 15 | 28 |
| 2012 | 11 | 33 |
| 2013 | 21 | 32 |
| 2014 | 20 | 36 |
| 2015 | 29 | 43 |
| 2016 | 26 | 64 |
| 2017 | 37 | 47 |
| 2018 | 33 | 108 |
| 2019 | 65 | 103 |
| 2020 | 59 | 98 |
| 2021 | 58 | 89 |
| 2022 | 58 | 104 |
| 2023 | 47 | 108 |
| 2024 | 46 | 115 |
| 2025 | 37 | 97 |
| 2026 | 30 | 55 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- CAS12B enzymes and systems6 Oct 2026US 12,753,406 B2Massachusetts Institute of Technology
- Riboswitch modulated gene therapy for retinal diseases29 Sep 2026US 12,747,441 B2The Medical College of Wisconsin, Inc.
- Endosomal cleavable linkers15 Sep 2026US 12,735,702 B2Alnylam Pharmaceuticals, Inc.
- RNA molecules, methods of producing circular RNA, and treatment methods15 Sep 2026US 12,737,877 B2Cornell University
- Conditional-siRNAs and uses thereof in treating acute myeloid leukemia7 Jul 2026US 12,674,164 B2California Institute of Technology
- Methods of minimising effects of smoke exposure8 Oct 2026US 2026/0308597 A1Rage Biotech Pty Ltd
- Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof17 Sep 2026US 2026/0273070 A1City of Hope
- Methods of treating pulmonary fibrosis10 Sep 2026US 2026/0265758 A1Rage Biotech Pty Ltd
- Fah-modulating compositions and methods3 Sep 2026US 2026/0258424 A1Flagship Pioneering Innovations VI, LLC
- Systems for enhancing mrna expression and uses thereof27 Aug 2026US 2026/0248960 A1The Johns Hopkins University
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes457US 8,932,814 B2Massachusetts Institute of Technology · 2015
- CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes432US 8,889,356 B2Massachusetts Institute of Technology · 2014
- CRISPR enzymes and systems331US 9,790,490 B2Massachusetts Institude of Technology · 2017